Ładuje się......
The rule of five should not impede anti-parasitic drug development
The “rule of 5” has become a mainstay of decision-making in the pharmaceutical industry as well as in nonindustrial (academic and institutional) drug development. However the authors of the original paper never intended for “double cutoffs” to preclude development of new drug leads for parasitic dis...
Zapisane w:
| Wydane w: | Int J Parasitol Drugs Drug Resist |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Elsevier
2017
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5473536/ https://ncbi.nlm.nih.gov/pubmed/28623818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijpddr.2017.05.003 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|